NAUT
Price
$0.78
Change
-$0.01 (-1.27%)
Updated
Apr 14 closing price
Capitalization
98.66M
21 days until earnings call
RLAY
Price
$2.57
Change
+$0.15 (+6.20%)
Updated
Apr 14 closing price
Capitalization
435.67M
16 days until earnings call
Ad is loading...

NAUT vs RLAY

Header iconNAUT vs RLAY Comparison
Open Charts NAUT vs RLAYBanner chart's image
Nautilus Biotechnolgy
Price$0.78
Change-$0.01 (-1.27%)
Volume$150.5K
Capitalization98.66M
Relay Therapeutics
Price$2.57
Change+$0.15 (+6.20%)
Volume$2.6M
Capitalization435.67M
NAUT vs RLAY Comparison Chart
Loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAUT vs. RLAY commentary
Apr 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAUT is a StrongBuy and RLAY is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 15, 2025
Stock price -- (NAUT: $0.78 vs. RLAY: $2.57)
Brand notoriety: NAUT and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAUT: 98% vs. RLAY: 104%
Market capitalization -- NAUT: $98.66M vs. RLAY: $435.67M
NAUT [@Biotechnology] is valued at $98.66M. RLAY’s [@Biotechnology] market capitalization is $435.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $281.29B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAUT’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • NAUT’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than NAUT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAUT’s TA Score shows that 5 TA indicator(s) are bullish while RLAY’s TA Score has 5 bullish TA indicator(s).

  • NAUT’s TA Score: 5 bullish, 2 bearish.
  • RLAY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NAUT is a better buy in the short-term than RLAY.

Price Growth

NAUT (@Biotechnology) experienced а -2.74% price change this week, while RLAY (@Biotechnology) price change was +25.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.53%. For the same industry, the average monthly price growth was -13.77%, and the average quarterly price growth was -22.20%.

Reported Earning Dates

NAUT is expected to report earnings on Aug 05, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($436M) has a higher market cap than NAUT($98.7M). RLAY YTD gains are higher at: -37.621 vs. NAUT (-53.446). NAUT has higher annual earnings (EBITDA): -75.12M vs. RLAY (-380.21M). RLAY has more cash in the bank: 781M vs. NAUT (130M). NAUT has less debt than RLAY: NAUT (30.5M) vs RLAY (48.5M). RLAY has higher revenues than NAUT: RLAY (10M) vs NAUT (0).
NAUTRLAYNAUT / RLAY
Capitalization98.7M436M23%
EBITDA-75.12M-380.21M20%
Gain YTD-53.446-37.621142%
P/E RatioN/AN/A-
Revenue010M-
Total Cash130M781M17%
Total Debt30.5M48.5M63%
FUNDAMENTALS RATINGS
NAUT: Fundamental Ratings
NAUT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAUTRLAY
RSI
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 5 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
76%
Momentum
ODDS (%)
N/A
Bearish Trend 5 days ago
88%
MACD
ODDS (%)
Bullish Trend 5 days ago
83%
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 5 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
88%
Advances
ODDS (%)
Bullish Trend 30 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
82%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 5 days ago
77%
Aroon
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
86%
View a ticker or compare two or three
Ad is loading...
NAUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FRNKX14.50N/A
N/A
Frank Value Inv
AMKIX10.89N/A
N/A
American Century Emerging Markets I
FDSSX70.94N/A
N/A
Fidelity Stock Selec
AREDX24.82N/A
N/A
American Century Real Estate R6
TVOCX30.88N/A
N/A
Touchstone Small Cap Value C

NAUT and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAUT has been loosely correlated with FHTX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if NAUT jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAUT
1D Price
Change %
NAUT100%
-1.13%
FHTX - NAUT
52%
Loosely correlated
+4.06%
KYMR - NAUT
51%
Loosely correlated
+5.43%
TECH - NAUT
50%
Loosely correlated
+3.58%
ABOS - NAUT
46%
Loosely correlated
-0.90%
RLAY - NAUT
44%
Loosely correlated
+6.20%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+6.20%
XNCR - RLAY
50%
Loosely correlated
+4.68%
RXRX - RLAY
46%
Loosely correlated
-4.34%
BCYC - RLAY
45%
Loosely correlated
+5.52%
BDTX - RLAY
44%
Loosely correlated
+0.72%
VCYT - RLAY
44%
Loosely correlated
+1.07%
More